2011 Executive Compensation Schedule for Onyx Pharmaceuticals, Inc.

Contract Categories: Human Resources › Compensation Agreements
Summary

This document outlines the 2011 base salaries, 2010 cash bonuses, and 2011 equity compensation awards for key executives at Onyx Pharmaceuticals, Inc. It lists the names, titles, and compensation details for each executive, including salary, bonus, stock options, restricted stock awards, and restricted stock units. The vesting schedules for each type of equity award are specified, with some awards subject to performance objectives to be met by January 1, 2014, or they will be forfeited.

Read More Arrow
EX-10.19 2 f58195exv10w19.htm EX-10.19 exv10w19
EXHIBIT 10.19
Base Salaries for Fiscal Year 2011, Cash Bonuses for Fiscal Year 2010 and 2011 Equity Compensation Awards
                                         
                    2011 Stock   2011 Restricted   2011 Restricted
                    Option Grant (1)   Stock Award (2)   Stock Units (3)
Name and Title   2011 Salary   2011 Bonus   (shares)   (shares)   (shares)
N. Anthony Coles, M.D.
   $ 701,000     $ 452,920       105,000       15,000       50,000  
President and Chief Executive Officer
                                        
 
                                        
Matthew K. Fust
   $ 452,100     $ 159,970       42,000       6,000       22,500  
Executive Vice President and Chief Financial Officer
                                        
 
                                        
Laura Brege
   $ 487,100     $ 170,122       35,000       5,000       22,500  
Executive Vice President, Corporate Affairs
                                        
 
                                        
Juergen Lasowski, Ph.D.
   $ 406,600     $ 136,537       78,500 (4)     5,500       22,500  
Executive Vice President, Corporate Development & Strategy
                                        
 
                                        
Suzanne M. Shema, J.D.
   $ 396,900     $ 137,480       38,500       5,500       12,500  
Senior Vice President, General Counsel
                                        
 
(1)   One-eighth of the shares subject to the stock options will vest on the six month anniversary of the date of grant and the remaining shares will vest in equal monthly installments over the following 42 months.
 
(2)   One-third of the shares subject to the restricted stock award will vest on the one year anniversary of the date of grant and the remaining shares will vest in two equal installments on the second and third anniversaries of the date of grant.
 
(3)   The restricted stock units are subject to performance objectives set by the Compensation Committee (the “Committee”) of the Board of Directors and will vest in full or part based on achievement of the performance metrics. If the Committee concludes that the goals have not been met by January 1, 2014, the shares will be forfeited.
 
(4)   This stock option grant includes 40,000 stock options, which will vest in equal monthly installments over 48 months.